Estimation of DNA damage and cytotoxicity of anthracycline analogs in human melanoma cells on early and late passages

Acta Poloniae Pharmaceutica - Drug Research

Volumn 63, Issue 4, 2006, Pages 321-324

  Anuszewska, Elzbieta ^a   Chłopkiewicz, Bozena ^a   Gruber, Beata ^a   Marczewska, Jadwiga ^a   Priebe, Waldemar ^b   Skurzak, Henryk ^c  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Anthracyclines; Cytotoxicity; DNA damage; Human melanoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTHRACYCLINE DERIVATIVE; ANTHRACYCLINE; ANTINEOPLASTIC ANTIBIOTIC; DNA; DOXORUBICIN; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ARTICLE; CANCER PATIENT; CANCER RESISTANCE; CELL DEATH; COMET ASSAY; DNA DAMAGE; DRUG CYTOTOXICITY; GENOME; HUMAN; HUMAN CELL; IC 50; MELANOMA CELL; DRUG EFFECT; MELANOMA; PATHOLOGY; TUMOR CELL LINE;

ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; COMET ASSAY; DNA DAMAGE; DNA, NEOPLASM; DOXORUBICIN; HUMANS; INDICATORS AND REAGENTS; MELANOMA;

EID: 33846898796     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Karst A.M., Dai D.L., Martinka M, Li G.: Oncogene 24, 1111 (2005).
2. Neuman A.S., Sturgis E.M., Wei Q.: Mol. Carcinog. 42, 65 (2005).
3. Gruber B.M., Anuszewska E.L.: Bull. Drug Inst. 45, 569 (2001).
4. Gruber B.M., Anuszewska E.L.: Bull. Drug Inst. 46, 31 (2002).
5. Kulik J., Nowecki Z.I., Rutkowski P., Ruka W., Grochowska M., Skurzak H., Siedlecki J.A.: Melanoma Res. 11, 65 (2001).
6. Mosmann T.: J. Immunol. Methods 65, 55 (1983).
7. Gruber B.M., Anuszewska E.L.: Bull. Drug Inst. 38, 5 (1994).
8. Singh N.P., MacCoy M.T., Tice R.R., Schneider E.L.: Exp. Cell Res. 175, 184 (1988).
9. Ejchart A., Chłopkiewicz B.: Bull. Drug Inst. 43, 9 (1999).
10. Östling O., Johanson K.J.: Biochem. Biophys. Res. Commun. 123, 291 (1984).
11. McNamee J.P., McLean J.R.N., Ferratto C.L. and Bellier P.V.: Mutation Res. 466, 63 (2000).
12. Rojas E., Lopez M.C., Valverde M.: J. Chromatogr. B 722, 225 (1999).
13. Gewirtz D.A.: Biochem. Pharmacol. 57, 727 (1999).